Comment on “Analysis of Pharmacokinetic and Pharmacodynamic Parameters in EU-Versus US-Licensed Reference Biological Products: Are In Vivo Bridging Studies Justified for Biosimilar Development?”
Source: BioDrugs - Category: Drugs & Pharmacology Source Type: research
More News: Drugs & Pharmacology | Study